Answers are grounded in this paper and cite their sources.
Monoclonal gammopathy of undetermined significance (MGUS) is an asymptomatic premalignant plasma cell disorder that is characterized by the presence of serum M-protein less than 30 g/L or 3 g/dL, bone marrow (BM) clonal plasma cells less than 10%, absence of plasma cell myeloma (PCM) related end-organ damage (CRAB symptoms: hypercalcemia, renal insufficiency, anemia and, bone lesions) and absence of B-cell lymphoma or other disease known to produce an M-protein. MGUS is generally considered a preneoplastic disorder that does not always progress to overt malignancy (1, 2). Diverse endocrinopathies occur in patients with plasma cell disorders (3-6). One possible scenario is the rather rare POEMS syndrome, which is a paraneoplastic syndrome with key manifestations of polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes (7). We present a case study which emphasizes the importance of multidisciplinary evaluation of MGUS.
No takes yet. Share an insight, caveat, or question.
Miletić et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: